Updated Jul 16, 2026
Deferiere Raphael has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Raphael Deferiere is the Chief Accounting Officer at Centessa Pharmaceuticals plc, a biopharmaceutical company focused on developing medicines for patients with unmet medical needs. He has a background in accounting and finance, contributing to the financial operations of the company.
| Role | Chief Accounting Officer |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-24 | CNTA | Centessa Pharmaceuticals plc | D — Derivative transaction | 11.0K | — | |
| 2026-02-04 | CNTA | Centessa Pharmaceuticals plc | A — Grant or award | 11.0K | $0.00 |
Raphael Deferiere is the Chief Accounting Officer at Centessa Pharmaceuticals plc, a biopharmaceutical company focused on developing medicines for patients with unmet medical needs. He has a background in accounting and finance, contributing to the financial operations of the company.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Deferiere Raphael profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.